• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. ACTIVA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. ACTIVA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR Back to Search Results
Model Number 37603
Device Problems Inappropriate/Inadequate Shock/Stimulation (1574); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Fatigue (1849); Muscle Spasm(s) (1966); Complaint, Ill-Defined (2331); Cognitive Changes (2551); Electric Shock (2554)
Event Date 01/21/2016
Event Type  Injury  
Event Description
Information received from a clinical patient reported the patient experienced a stroke after the physician turned their device on/off on (b)(6) 2015.The physician was ¿turning the stimulation on and then it gave [the patient] a stroke, not they didn't turn it on they turned [the device] off and they gave [the patient] a stroke.¿ indications for use included dystonia and movement disorders.See manufacturing report 3004209178-2016-27100.
 
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Concomitant medical products: product id 37603, serial# (b)(4), implanted: (b)(6) 2015, explanted: (b)(6) 2016, product type: implantable neurostimulator.(b)(4).A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from a health care provider (hcp) of a clinical study via a manufacturer representative (rep).It was reported that the health care provider (hcp) has no records or knowledge regarding an appointment on (b)(6) 2015.It was noted however, that the patient had a visit on (b)(6) 2016 and reported that on the day prior, the patient and their spouse were adjusting the deep brain stimulation (dbs) and it caused a spasm in the patient's left arm and face that lasted for about 45 seconds before completely resolving.There was some concern that this represented a stroke or tia, but it occurred precisely at the time that the dbs was restarted.An mri of the patient's brain was performed, but no abnormalities were found.The hcp's assessment/synopsis was noted as: the patient's nih stroke scale/score (nissh) was very low, their symptoms are rapidly improving and their neurologic exam is more consistent with alcohol than stroke.The hcp also noted that they would check urine drug screen (uds) and ethyl alcohol (etoh) levels as the patient appeared intoxicated.A ct scan of the patient's head and a ct perfusion were performed and showed an unrelated long segment of complete occlusion of the right vertebral artery with reconstitution as well as apparent perfusion defect involving the left anterior mca territory surrounding the brain stimulator, which could be artificial.The final diagnosis included an altered mental status and alcohol intoxication.The patient's discharge diagnosis on (b)(6) 2016 included "altered mental status, resolved".Another follow-up appointment was conducted on (b)(6) 2016 where the patient presented with two spells.The first spell was related to deep brain stimulation (dbs) in that when the device is suddenly turned on, the patient gets a "jolt" and "can have drawing of the face".The hcp stated that they feel this is expected and is not indicative of tia.The second spell was noted to be likely related to the alcohol, fatigue, and a fall; the hsp did not think either spell was a tia or stroke.However, the hcp noted that they thought the new vertebral artery occlusion was most likely due to an unrelated atherosclerosis, as there was "some plaque seen at the origin of vert on the right and then is occluded".The hcp thought the patient was at risk for stroke and felt that the patient should continue asa and statin.The patient's medical history included: hyperlipidemia, bipolar, and pseudoseizures and dystonia.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACTIVA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer Contact
lisa clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key6200404
MDR Text Key63174320
Report Number3004209178-2016-27101
Device Sequence Number1
Product Code MRU
UDI-Device Identifier00613994761071
UDI-Public00613994761071
Combination Product (y/n)N
PMA/PMN Number
H020007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date 02/15/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/22/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/14/2016
Device Model Number37603
Device Catalogue Number37603
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received02/10/2017
Date Device Manufactured06/16/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age51 YR
-
-